Icon

LOVENOX (nda020164)- (300MG/3ML (100MG/ML))

ENOXAPARIN SODIUM SANOFI AVENTIS US
300MG/3ML (100MG/ML)
Yes No
2012-Feb-14 Expired
None None
None No
Lovenox is a low molecular weight heparin [LMWH] indicated for: • Prophylaxis of deep vein thrombosis (DVT) in abdominal surgery, hip replacement surgery, knee replacement surgery, or medical patients with severely restricted mobility during acute illness • Inpatient treatment of acute DVT with or without pulmonary embolism • Outpatient treatment of acute DVT without pulmonary embolism. • Prophylaxis of ischemic complications of unstable angina and non-Q-wave myocardial infarction [MI] • Treatment of acute ST-segment elevation myocardial infarction [STEMI] managed medically or with subsequent percutaneous coronary intervention [PCI]
3 0 2
Total Other Developers None
Drugs with Suitability No
300MG/3ML (100MG/ML) ** ** - - 2
NDA Sales Available Total Generic Sales Available
Yes 2
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* ****** *** ********* ***************, ***. *********** ***** *** ******, ****** *********, ********** (**) *****, ****** ****** (***) ***
****** ******* ****-****** ******* ****-****** *********** ************** **.,***. (*** ****) *********** **, ** ***** ****, ******* **** *** *** ********** *********** **** ******* ******, *******, ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.